Get started

Vaccines

NVAX- Dark horse in the vaccine raceNo one can predict the result of NVAX's phase 3 trial. However, I don't count out any potential winners in the vaccine race even though now it seems very likely that NVAX won't be the first one to distribute vaccines at massive scale. That being said, as long as the result of phase 3 trial isn't a complete failure, I think the crowd frenzy will keep pushing NVAX's price up. To be on the safe side, I would market buy 33% of my overall position and limit buy the remaining in the demand zone. Just my opinion. Not the investment advice.
NASDAQ:NVAXLong
by Libratus
Descent in the SPX (October 26th-November 9th 2020)S&P 500 Index (SPX) (October 26th through November 9th 2020) Low: 3362.9 points High: 3455 points How E-mini futures market started off yesterday: My previous SPX forecast: My adjustments today are more to correct the trajectory and duration I was originally expecting. Will be interesting to see how this spooky week turns out. Time for temporary bloodbath just before halloween? ;) Thanks for tuning in :) Disclaimer, I am not responsible for any losses incurred while attempting to use my data, I hope this can prove to be some sort of learning tool for some and give insight as to how I personally come up with my own numbers. Take into full consideration this could be a completely bad forecast. Cheers
TVC:SPXShort
by Hambooger
U-Shape? V-Shape? Recovery Shapes Explained And What They Mean ?🎈 Here are the most common economic recovery shapes and what they mean. While economic growth can be measured by any number of metrics—like the stock market or employment rates for example—we’ll focus on GDP. 📍 A V-shaped recovery means that the economy bounces back quickly to its baseline before the crisis, with no hiccups along the way. Growth continues at the same rate as before. This is one of the most optimistic recovery patterns because it implies that the downturn did not cause any lasting damage to the economy. Under this scenario, the economic damage lasts for a longer period of time before eventually reaching the baseline level of growth again. The economy bounces back, but the damage at the bottom lingers for a while. 📍 In a W-shaped recession, also called a double dip, the economy moves beyond a recession into a period of recovery before falling back down again into another recession. The initial recovery is sometimes known as a bear market rally. One example: After the oil and inflation crises in 1979, the U.S. fell into two back-to-back recessions in 1980 and 1981. 📍 An L-shaped recovery is the most pessimistic scenario. In this shape, the economy recovers to a certain degree from a steep drop, but growth never reaches pre-crisis levels for years, if at all. A period of economic stagnation follows. 📍 A recovery scenario resembling the Nike “swoosh” logo is characterized by a steep drop and a gradual recovery, meaning that it takes much longer to return to pre-crisis growth levels than it took to fall into recession. A variant of this is a square root-shaped recession where growth recovers but then plateaus before reaching pre-crisis levels. Lowenstein says this is his base case scenario. feel Free to comment below Your Ideas to make things more better. Thank you 🙏
Editors' picks
BITSTAMP:BTCUSDEducation
by Ridethemacro
22
[NVAX] Novavax: Preliminary studies produce promising resultsPreliminary studies on coronavirus vaccines have produced promising results. I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will hopefully pave the way for vaccines going forward. Things to watch even after COVID-19: - NanoFlu™ - ResVax™ - Recombinant Nanoparticle Vaccine Technology - Matrix-M™ Adjuvant Technolog TL;DR - To the moon and (probably) back lol *Note: This is pure speculation and my own opinion* NY Times: www.nytimes.com CNBC: www.cnbc.com
NASDAQ:NVAXLong
by traderman001
2
A trading plan on MicrosoftOn its earnings report today, Microsoft reported better-than-expected earnings and guidance, but issued first-quarter revenue guidance slightly below the Wall Street consensus. The poor revenue guidance was partly, but not completely, offset by slightly better-than expected guidance for first-quarter operating costs. Overall, the magnitude of the earnings beat was much greater than the magnitude of the guidance cut, and my valuation metrics on Microsoft improved today: PEG dropped from 9+ to about 8.76. Microsoft is still certainly overvalued, however, along with the rest of the FAANG+ stocks. It's about 30-40% above the top end of its traditional range in terms of forward P/E and P/S. For a long-term buy-and-hold play, I would want to see Microsoft drop all the way to my second volume support before I'd want to buy. In the short term, Microsoft sentiment still looks pretty good. Options traders are net bullish in their positioning, and the Starmine Equity Summary Score for MSFT is 9.9. ESG has mattered a lot lately, and Microsoft earns one of the best ESG ratings I've seen. Thus I think we'll probably see a bounce from 203 either tomorrow or, more likely, Monday or Tuesday next week. A swing trade over the weekend might be a winner as the market holds out hope for vaccine and stimulus news. In macroeconomic terms, we saw the "recovery" story start to change today. Initial jobless claims turned upward for the first time in 16 weeks. Lots of other indicators I watch are also starting to look a little more negative. Thus, we may be headed into a period of renewed market weakness until the South and Midwest successfully flatten their coronavirus curves and resume reopening their economies. I highly doubt we'll drop all the way to that lower volume support at $135 unless the Moderna, Pfizer, and Astrazeneca vaccines all fail in clinical trials, but a dip to the upper support around $183.50 in August or September after stimulus news fades may not be out of the question, and from there it'd be worth swinging for a bounce. I will target a small entry at $183.50 and a 3x larger entry for $135, contingent on macroeconomic news.
NASDAQ:MSFT
by ChristopherCarrollSmith
8